Results 131 to 140 of about 6,058,096 (352)

Dimensionality reduction of independent influence factors in the objective evaluation of quality of experience. [PDF]

open access: yesSci Rep, 2022
Skaka-Čekić F   +5 more
europepmc   +1 more source

The Privatization of Sensation [PDF]

open access: yes, 2000
It is the ambition of evolutionary psychology to explain how the basic features of human mental life came to be selected because of their contribution to biological survival.
Humphrey, Nicholas
core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Past Unemployment Experience and Health Status [PDF]

open access: yes, 2007
This paper explores the relationship between individual past unemployment experience and alternative measures of individual health state after controlling for a number of current characteristics and current socio-economic status.
Economou, Athina   +2 more
core   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

The importance of older patients’ experiences with care delivery for their quality of life after hospitalization [PDF]

open access: gold, 2015
Jacqueline M. Hartgerink   +4 more
openalex   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy